New issue received!
Table of content:
Body Image in Men with HIV
Abstract
Antiretroviral Medication Considerations for Individuals Coinfected with HIV and Hepatitis C Virus
Abstract
Client Satisfaction with Rapid HIV Testing: Comparison Between an Urban Sexually Transmitted Disease Clinic and a Community-Based Testing Center
Abstract
A Measurement Model of Medication Adherence to Highly Active Antiretroviral Therapy and Its Relation to Viral Load in HIV-Positive Adults
Abstract
Are Psychological Consequences of Stigma Enduring or Transitory? A Longitudinal Study of HIV Stigma and Distress Among Asians and Pacific Islanders Living with HIV
Abstract
Prevalence and Correlates of HIV Serostatus Disclosure: A Prospective Study Among HIV-Infected Postparturient Women in Barbados
Abstract
Antiviral Briefs
Citation
Drug Development and STD News
Citation
Request a copy of article
Wednesday, November 15, 2006
Tuesday, November 14, 2006
HIV Infection Linked With Lung Disease
U.S. medical scientists suggest patients who are HIV positive may be at an increased risk for developing chronic obstructive pulmonary disease.
The researchers from Yale University School of Medicine investigated the prevalence of COPD among 1,014 HIV-positive and 713 HIV-negative men enrolled in the Veterans Aging Cohort 5 Site Study.
Results showed the prevalence of COPD was 10 percent in HIV-positive and 9 percent in HIV-negative patients -- as reported by clinicians, and 15 percent and 12 percent, in that order, as indicated by patient self-reporting.
(http://www.playfuls.com/news_002905_HIV_Infection_Linked_With_Lung_Disease.html)
The researchers from Yale University School of Medicine investigated the prevalence of COPD among 1,014 HIV-positive and 713 HIV-negative men enrolled in the Veterans Aging Cohort 5 Site Study.
Results showed the prevalence of COPD was 10 percent in HIV-positive and 9 percent in HIV-negative patients -- as reported by clinicians, and 15 percent and 12 percent, in that order, as indicated by patient self-reporting.
(http://www.playfuls.com/news_002905_HIV_Infection_Linked_With_Lung_Disease.html)
Thursday, November 09, 2006
Building A 'Molecular' Condom, Scientists Aim To Stop HIV
CINDY TUMIEL
c. 2006 San Antonio Express-News
Distributed by The New York Times Syndicate
The idea is to create a long-acting "molecular condom" that could empower women and save lives in the world's poorest countries where HIV is rampant, and where other methods of preventing disease are not readily available or used.
Presenting their research at a meeting here, scientists in Utah are developing a gel that coats the vagina, forming a chemical barrier.
To that barrier could be added microbicides that kill HIV and other infectious diseases. The gel is still in early stages of development and years away from being tested in people. But researchers are hopeful their product will eventually be accepted and available in Africa and other Third World countries, where women are considered the group most at risk for transmission of HIV.
Read the article
c. 2006 San Antonio Express-News
Distributed by The New York Times Syndicate
The idea is to create a long-acting "molecular condom" that could empower women and save lives in the world's poorest countries where HIV is rampant, and where other methods of preventing disease are not readily available or used.
Presenting their research at a meeting here, scientists in Utah are developing a gel that coats the vagina, forming a chemical barrier.
To that barrier could be added microbicides that kill HIV and other infectious diseases. The gel is still in early stages of development and years away from being tested in people. But researchers are hopeful their product will eventually be accepted and available in Africa and other Third World countries, where women are considered the group most at risk for transmission of HIV.
Read the article
Wednesday, November 08, 2006
Website of the week
Each week, you will find on this blog a selection of websites which you may find of interest.
Let's start with one of the most important web resources on HIV/AIDS: The Body : http://www.thebody.com
With over 550 topic areas covered by experts from 100 organizations, The Body is a wealth of information for anybody looking for information on living with HIV.
Ask the experts, Bulletin boards and inspiring stories are just a few features of this constantly updated website.
Send us your suggestions for the Website of the week!
Let's start with one of the most important web resources on HIV/AIDS: The Body : http://www.thebody.comWith over 550 topic areas covered by experts from 100 organizations, The Body is a wealth of information for anybody looking for information on living with HIV.
Ask the experts, Bulletin boards and inspiring stories are just a few features of this constantly updated website.
Send us your suggestions for the Website of the week!
Monkey form of HIV may be endemic in wild gorillas
By Patricia Reaney
LONDON (Reuters) - A monkey virus similar to HIV is endemic in wild gorillas in Africa and was probably transmitted to them by chimpanzees, researchers said on Wednesday.
About 40 million people worldwide are living with HIV/AIDS.
The origins of two of the three strains of the virus in humans have been traced back to monkeys in Africa infected with simian immunodeficiency virus (SIV) but the source of the third has been unknown, until now.
"It is the first time that someone has done a survey among wild gorillas to see whether they were infected with an SIV," said Martine Peeters, a virologist at the University of Montpellier in France.
Read the article "Monkey form of HIV may be endemic in wild gorillas"
LONDON (Reuters) - A monkey virus similar to HIV is endemic in wild gorillas in Africa and was probably transmitted to them by chimpanzees, researchers said on Wednesday.
About 40 million people worldwide are living with HIV/AIDS.
The origins of two of the three strains of the virus in humans have been traced back to monkeys in Africa infected with simian immunodeficiency virus (SIV) but the source of the third has been unknown, until now.
"It is the first time that someone has done a survey among wild gorillas to see whether they were infected with an SIV," said Martine Peeters, a virologist at the University of Montpellier in France.
Read the article "Monkey form of HIV may be endemic in wild gorillas"
1991: Magic Johnson tests positive for HIV
Nov. 7, 1991: "With an announcement that stunned the nation, Earvin 'Magic' Johnson, the brilliant guard who was the marquee name for the Lakers and the National Basketball Assn. for 12 years, retired … saying he had tested positive for the virus that causes AIDS," The Times reported."
Johnson, 32, was characteristically upbeat when he made the announcement at a packed news conference at the Forum in Inglewood. Flashing his trademark smile, he stressed that while he is infected with the human immunodeficiency virus, he has not developed AIDS. Johnson said he intends to remain active in basketball off the court and that he will become a spokesman for AIDS prevention. "I plan to go on living for a long time," he said.
In one of two front-page articles, The Times described public reaction to the news that "an icon had been shot down in mid-stride." "The news was treated like the death of a head of state or the outbreak of war," the article said.Source : L.A. Times
New AIDS Therapy Nukes HIV With Radioactive Antibodies
Like guided missiles, radioactive anti-HIV antibodies seek out and destroy HIV-infected cells.
The new approach to AIDS therapy -- called radioimmunotherapy -- works in mice, report Ekaterina Dadachova, PhD, of New York's Albert Einstein College of Medicine, and colleagues.
"Radioimmunotherapy is supposed to be curative," Dadachova tells WebMD. "Current HIV treatments kill the virus, but it will come back because it hides in latently infected cells. Our goal is to go after those cells, so radioimmunotherapy has the potential to cure somebody completely."
Dadachova's colleague, Harris Goldstein, MD, tempers his enthusiasm a bit more. Goldstein is director of the Einstein/MMC Center for AIDS Research in New York.
"If we had a nickel for every time HIV was cured we'd all be very wealthy," Goldstein tells WebMD. "But it is exciting when a new conceptual approach comes along. What makes this treatment unique is that it is designed to target HIV infected cells and kill them. This really has the potential to markedly reduce the viral infection in patients."
More on Fox News
The new approach to AIDS therapy -- called radioimmunotherapy -- works in mice, report Ekaterina Dadachova, PhD, of New York's Albert Einstein College of Medicine, and colleagues.
"Radioimmunotherapy is supposed to be curative," Dadachova tells WebMD. "Current HIV treatments kill the virus, but it will come back because it hides in latently infected cells. Our goal is to go after those cells, so radioimmunotherapy has the potential to cure somebody completely."
Dadachova's colleague, Harris Goldstein, MD, tempers his enthusiasm a bit more. Goldstein is director of the Einstein/MMC Center for AIDS Research in New York.
"If we had a nickel for every time HIV was cured we'd all be very wealthy," Goldstein tells WebMD. "But it is exciting when a new conceptual approach comes along. What makes this treatment unique is that it is designed to target HIV infected cells and kill them. This really has the potential to markedly reduce the viral infection in patients."
More on Fox News
Monday, November 06, 2006
First HIV Gene Therapy Test Encouraging
By RANDOLPH E. SCHMID
The Associated PressMonday, November 6, 2006; 6:19 PM
WASHINGTON --
"The first test of a potential new gene therapy for HIV _ the virus that causes AIDS _ was encouraging enough for researchers to launch a more extensive trial.
"The goal of this phase I trial was safety and feasibility, and the results established that," said lead researcher Dr. Carl June. "But the results also hint at something much more."
In addition to showing that the treatment was possible and didn't endanger the patients, the amount of virus in the subjects remained steady or decreased during the study, which involved just five people with chronic HIV infection.
One patient had a sustained decrease in the amount of virus, and immune cells and strength of the immune system increased in four patients during the nine-month study..."
Article available on the Washington Post's website.
The Associated PressMonday, November 6, 2006; 6:19 PM
WASHINGTON --
"The first test of a potential new gene therapy for HIV _ the virus that causes AIDS _ was encouraging enough for researchers to launch a more extensive trial.
"The goal of this phase I trial was safety and feasibility, and the results established that," said lead researcher Dr. Carl June. "But the results also hint at something much more."
In addition to showing that the treatment was possible and didn't endanger the patients, the amount of virus in the subjects remained steady or decreased during the study, which involved just five people with chronic HIV infection.
One patient had a sustained decrease in the amount of virus, and immune cells and strength of the immune system increased in four patients during the nine-month study..."
Article available on the Washington Post's website.
Culture, health & sexuality, Vol. 8, no 6
Received today at the library!
Table of contents with links to abstracts:
Homosexuality, seropositivity, and family obligations: Perspectives of HIV‐infected men who have sex with men in China
pp. 487 - 500
Remaking the masculine self and coping in the liminal world of the gay ‘scene’
pp. 501 - 514
Social scripts and stark realities: Kenyan adolescents' abortion discourse
pp. 515 - 528
Community preparedness for HIV vaccine trials in the Democratic Republic of Congo
pp. 529 - 544
Manufacturing heterosexuality: Hormone replacement therapy and menopause in urban Oaxaca pp. 545 - 558
‘Snag bags’: Adapting condoms to community values in Native American communities
pp. 559 - 570
Request a copy of any article!
Thursday, November 02, 2006
Dark Crystal - A CBC documentary
"Sweeping across the towns and cities of western Canada and headed eastward at an alarming paceis the drug known as crystal meth.
It's more addictive than heroin or cocaine at a fraction of the cost and the high it gives can last for days. And, unlike heroin or cocaine, it can be cooked up in an kitchen or basement lab using a recipe posted on internet sites and with ingredients found on the shelves at the local pharmacy. "
The website includes facts on crystal meth, information on crystal meth across Canada, the story of two B.C. towns, how to beat the addiction and online resources.
Watch the entire documentary online:
http://www.cbc.ca/fifth/darkcrystal/index.html
It's more addictive than heroin or cocaine at a fraction of the cost and the high it gives can last for days. And, unlike heroin or cocaine, it can be cooked up in an kitchen or basement lab using a recipe posted on internet sites and with ingredients found on the shelves at the local pharmacy. "
The website includes facts on crystal meth, information on crystal meth across Canada, the story of two B.C. towns, how to beat the addiction and online resources.
Watch the entire documentary online:
http://www.cbc.ca/fifth/darkcrystal/index.html
HIV Treatment Bulletin, October 2006
HIV Treatment Bulletin (htb) is a not-for-profit community publication that aims to provide a review of the most important medical advances related to clinical management of HIV and its related conditions as well as access to treatments. Comments to articles are compiled from consultant, author and editorial responses. Subscriptions are free.
The October issue is available at:
http://www.i-base.org.uk/pdf/htbvol7/htb7-10oct06.pdf
There's also a print copy in the library.
The October issue is available at:
http://www.i-base.org.uk/pdf/htbvol7/htb7-10oct06.pdf
There's also a print copy in the library.
Wednesday, November 01, 2006
New Study Compares HIV Drug Treatments
Regimens to treat HIV infection that are based on a non-nucleoside reverse transcriptase inhibitor (NNRTI) are at least as effective as treatment with a protease inhibitor but require patients to take fewer pills each day, according to a new study funded in part by HHS' Agency for Healthcare Research and Quality.
The study, published in the October 28 online issue of the Lancet, found that disease progression was similar for both regimens, but NNRTI-based treatment appeared more effective at decreasing the amount of virus in the blood. The number of patients who stopped treatment because of adverse events was similar for both medications.
The new study is the first to review all published research that directly compares the two classes of antiretroviral drugs used in highly active antiretroviral therapy (HAART). NNRTI-based regimens were found to be up to 60 percent more likely to suppress the amount of virus in patients' blood than protease inhibitor-based regimens. The percentage of patients who died or experienced disease progression were similar between the two treatments, and the number of patients who stopped taking the medications because of side effects or adverse events was also similar.
Read the complete article at http://www.axcessnews.com/modules/wfsection/article.php?articleid=11722
The study, published in the October 28 online issue of the Lancet, found that disease progression was similar for both regimens, but NNRTI-based treatment appeared more effective at decreasing the amount of virus in the blood. The number of patients who stopped treatment because of adverse events was similar for both medications.
The new study is the first to review all published research that directly compares the two classes of antiretroviral drugs used in highly active antiretroviral therapy (HAART). NNRTI-based regimens were found to be up to 60 percent more likely to suppress the amount of virus in patients' blood than protease inhibitor-based regimens. The percentage of patients who died or experienced disease progression were similar between the two treatments, and the number of patients who stopped taking the medications because of side effects or adverse events was also similar.
Read the complete article at http://www.axcessnews.com/modules/wfsection/article.php?articleid=11722
AIDS Care, Vol. 18, no 8
In this issue:
Girls’ schooling in Tanzania: the key to HIV/AIDS prevention?
pp. 863 - 871
Psychopathology of first-episode psychosis in HIV-positive persons in comparison to first-episode schizophrenia: A neglected issue
pp. 872 - 878
Safe sex after post-exposure prophylaxis for HIV: Intentions, challenges and ambivalences in narratives of gay men
pp. 879 - 887
‘We are no longer called club members but caregivers’: Involving youth in HIV and AIDS caregiving in rural Zambia
pp. 888 - 894
Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: Lessons learned from Project HEART
pp. 895 - 903
Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS
pp. 904 - 910
Characteristics of homeless HIV-positive outreach responders in urban US and their success in primary care treatment
pp. 911 - 917
Patterns of reasoning and decision making about condom use by urban college students
pp. 918 - 930
Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana
pp. 931 - 933
Association between risk of acquiring HIV and beliefs and perceptions about the lived experience of HIV/AIDS among HIV-negative or untested men who have sex with men
pp. 934 - 941
Differences between men who report frequent, occasional or no unprotected anal intercourse with casual partners among a cohort of HIV-seronegative gay men in Sydney, Australia
pp. 942 - 951
HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa
pp. 952 - 960
Violence and HIV-related risk among young men who have sex with men
pp. 961 - 967
Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations
pp. 968 - 976
Illness-related factors, stress and coping strategies in relation to psychological distress in HIV-infected persons in Hong Kong
pp. 977 - 982
Communication of HIV viral load to guide sexual risk decisions with serodiscordant partners among San Francisco men who have sex with men
pp. 983 - 989
Barebacking websites: electronic environments for reducing or inducing HIV risk
pp. 990 - 997
Body image in middle-aged HIV-infected and uninfected women
pp. 998 - 1003
Knowledge, attitudes and sources of information regarding HIV/AIDS in Iranian adolescents
pp. 1004 - 1010
Perceived stress in HIV-infected individuals: Physiological and psychological correlates
pp. 1011 - 1017
A community-based rapid assessment of HIV behavioural risk disparities within a large sample of gay men in southeastern USA: A comparison of African American, Latino and white men
pp. 1018 - 1024
Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: A controlled outcome study
pp. 1025 - 1031
The role of sympathy on avoidance intention toward persons living with HIV/AIDS in Jamaica
pp. 1032 - 1039
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users
pp. 1040 - 1045
Circuit parties: Sexual behaviors and HIV disclosure practices among men who have sex with men at the White Party, Palm Springs, California, 2003
pp. 1046 - 1049
Growing up: Perspectives of children, families and service providers regarding the needs of older children with perinatally-acquired HIV
pp. 1050 - 1053
Request a copy of any article
Girls’ schooling in Tanzania: the key to HIV/AIDS prevention?
pp. 863 - 871
Psychopathology of first-episode psychosis in HIV-positive persons in comparison to first-episode schizophrenia: A neglected issue
pp. 872 - 878
Safe sex after post-exposure prophylaxis for HIV: Intentions, challenges and ambivalences in narratives of gay men
pp. 879 - 887
‘We are no longer called club members but caregivers’: Involving youth in HIV and AIDS caregiving in rural Zambia
pp. 888 - 894
Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: Lessons learned from Project HEART
pp. 895 - 903
Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS
pp. 904 - 910
Characteristics of homeless HIV-positive outreach responders in urban US and their success in primary care treatment
pp. 911 - 917
Patterns of reasoning and decision making about condom use by urban college students
pp. 918 - 930
Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana
pp. 931 - 933
Association between risk of acquiring HIV and beliefs and perceptions about the lived experience of HIV/AIDS among HIV-negative or untested men who have sex with men
pp. 934 - 941
Differences between men who report frequent, occasional or no unprotected anal intercourse with casual partners among a cohort of HIV-seronegative gay men in Sydney, Australia
pp. 942 - 951
HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa
pp. 952 - 960
Violence and HIV-related risk among young men who have sex with men
pp. 961 - 967
Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations
pp. 968 - 976
Illness-related factors, stress and coping strategies in relation to psychological distress in HIV-infected persons in Hong Kong
pp. 977 - 982
Communication of HIV viral load to guide sexual risk decisions with serodiscordant partners among San Francisco men who have sex with men
pp. 983 - 989
Barebacking websites: electronic environments for reducing or inducing HIV risk
pp. 990 - 997
Body image in middle-aged HIV-infected and uninfected women
pp. 998 - 1003
Knowledge, attitudes and sources of information regarding HIV/AIDS in Iranian adolescents
pp. 1004 - 1010
Perceived stress in HIV-infected individuals: Physiological and psychological correlates
pp. 1011 - 1017
A community-based rapid assessment of HIV behavioural risk disparities within a large sample of gay men in southeastern USA: A comparison of African American, Latino and white men
pp. 1018 - 1024
Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: A controlled outcome study
pp. 1025 - 1031
The role of sympathy on avoidance intention toward persons living with HIV/AIDS in Jamaica
pp. 1032 - 1039
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users
pp. 1040 - 1045
Circuit parties: Sexual behaviors and HIV disclosure practices among men who have sex with men at the White Party, Palm Springs, California, 2003
pp. 1046 - 1049
Growing up: Perspectives of children, families and service providers regarding the needs of older children with perinatally-acquired HIV
pp. 1050 - 1053
Request a copy of any article
Subscribe to:
Posts (Atom)
